Sandbox:DN: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) |
||
Line 1: | Line 1: | ||
= | {| class="wikitable" | ||
! | |||
!Stress Cardiomyopathy | |||
!Anterior Wall MI | |||
|- | |||
|[[Chest pain]] and [[dyspnea]] as presenting symptoms | |||
|✔ | |||
|✔ | |||
|- | |||
|[[ST elevation]] in [[precordial leads]] | |||
|✔ | |||
|✔ | |||
|- | |||
|Peak [[CK-MB]] value | |||
|<50 U/L | |||
|↑↑↑ | |||
|- | |||
|6-month outcome | |||
|Favorable outcome | |||
|Higher rates of: | |||
* Death | |||
* Cardiac death | |||
* [[Reinfarction]] | |||
* Rehospitalization | |||
* Major cardiac events | |||
|} | |||
Stress cardiomyopathy must also be differentiated from Takotsubo-like syndrome caused by medical conditions, such as [[pheochromocytoma]]:<ref name="pmid23058349">{{cite journal |vauthors=Mikail N, Hess S, Jesel L, El Ghannudi S, El Husseini Z, Trinh A, Ohlmann P, Morel O, Imperiale A |title=Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway? |journal=Int. J. Cardiol. |volume=166 |issue=1 |pages=248–50 |year=2013 |pmid=23058349 |doi=10.1016/j.ijcard.2012.09.116 |url=}}</ref> | |||
{| class="wikitable" | |||
! | |||
!Stress Cardiomyopathy | |||
!Takotsobu-like Syndrome | |||
|- | |||
|[[Chest pain]] mimicking [[MI]] | |||
|✔ | |||
|✔ | |||
|- | |||
|[[EKG]] findings ([[ST elevation]]) | |||
|✔ | |||
|✔ | |||
|- | |||
|Positive [[cardiac enzymes]] | |||
|✔ | |||
|✔ | |||
|- | |||
|[[LV]] regional dysfunction | |||
|✔ | |||
|✔ | |||
|- | |||
|Patient profile | |||
|Post-menopausal women | |||
|Younger patients with less female predominance | |||
|- | |||
|[[Catecholamine]] levels | |||
|Transient elevation | |||
|Constantly elevated | |||
|- | |||
|Complications | |||
| | |||
|Higher rate of complications, including: | |||
* [[Cardiogenic shock]] | |||
* [[Heart failure]] | |||
* Low [[Ejection fraction|ejection fraction (EF)]] | |||
|} |
Revision as of 19:52, 13 January 2017
Stress Cardiomyopathy | Anterior Wall MI | |
---|---|---|
Chest pain and dyspnea as presenting symptoms | ✔ | ✔ |
ST elevation in precordial leads | ✔ | ✔ |
Peak CK-MB value | <50 U/L | ↑↑↑ |
6-month outcome | Favorable outcome | Higher rates of:
|
Stress cardiomyopathy must also be differentiated from Takotsubo-like syndrome caused by medical conditions, such as pheochromocytoma:[1]
Stress Cardiomyopathy | Takotsobu-like Syndrome | |
---|---|---|
Chest pain mimicking MI | ✔ | ✔ |
EKG findings (ST elevation) | ✔ | ✔ |
Positive cardiac enzymes | ✔ | ✔ |
LV regional dysfunction | ✔ | ✔ |
Patient profile | Post-menopausal women | Younger patients with less female predominance |
Catecholamine levels | Transient elevation | Constantly elevated |
Complications | Higher rate of complications, including: |
- ↑ Mikail N, Hess S, Jesel L, El Ghannudi S, El Husseini Z, Trinh A, Ohlmann P, Morel O, Imperiale A (2013). "Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway?". Int. J. Cardiol. 166 (1): 248–50. doi:10.1016/j.ijcard.2012.09.116. PMID 23058349.